Tyers Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.34M | Sell |
4,816
-64
| -1% | -$17.8K | 0.04% | 291 |
|
|
2019
Q2 | $1.53M | Sell |
4,880
-4,032
| -45% | -$1.26M | 0.05% | 262 |
|
|
2019
Q1 | $3.66M | Buy |
8,912
+6,000
| +206% | +$2.46M | 0.13% | 146 |
|
|
2018
Q4 | $1.09M | Buy |
2,912
+784
| +37% | +$293K | 0.04% | 270 |
|
|
2018
Q3 | $860K | Buy |
2,128
+480
| +29% | +$194K | 0.03% | 328 |
|
|
2018
Q2 | $569K | Buy |
1,648
+32
| +2% | +$11K | 0.02% | 401 |
|
|
2018
Q1 | $556K | Sell |
1,616
-272
| -14% | -$93.6K | 0.02% | 395 |
|
|
2017
Q4 | $710K | Buy |
1,888
+880
| +87% | +$331K | 0.02% | 348 |
|
|
2017
Q3 | $451K | Sell |
1,008
-48
| -5% | -$21.5K | 0.02% | 432 |
|
|
2017
Q2 | $519K | Sell |
1,056
-112
| -10% | -$55K | 0.02% | 400 |
|
|
2017
Q1 | $453K | Sell |
1,168
-16
| -1% | -$6.21K | 0.02% | 411 |
|
|
2016
Q4 | $435K | Buy |
+1,184
| New | +$435K | 0.02% | 377 |
|